Belite Bio (BLTE) Tops Q3 EPS by 1c

Belite Bio (NASDAQ: BLTE) reported Q3 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c
• Kioxia Plans To List Adrs In Us Around April Or May 2027 - Bloomberg